Iimfundiso malunga neepilisi zokukhupha nokuphelisa ukukhulelwa ngamachiza
NgoSeptemba 28, 2000, i-Food and Drug Administration (i-FDA) yamemezela imvume ye-RU-486. izidakamizwa eziphikisanayo ezidla ngokuba zibizwa ngokuthi " ipilisi yokukhupha isisu ." Inqunywe eUnited States ngegama elithi Mifeprex (mifepristone).
Isiza esasetyenzisiwe ngaphambili eYurophu yaye samukelwa ngokukhawuleza eUnited States. Emva kokuvunywa kwayo, inani elipheleleyo lokukhupha isisu liye lahla ngekota yesigidi ngonyaka ukususela ngo-2001 ukuya ku-2011.
Inani lokukhupha isisu liye lancipha ngokugqithiseleyo ngelixa inani lokukhupha izisu ezixutywayo likhula lenza phantse malunga nekota nganye.
I-FDA Iinguqu ngo-2016 kwi-Mifeprex
Amava oklinikhi okhuseleko lokukhupha isisu aguqulwe ukuguqula i-regimen evunyiweyo ye-FDA ngo-2016 evumela ukuba isetyenziswe kwiintsuku ezingama-70 zesigxina kwaye akudingi ukuba uhambele umntu ngomthamo we-misoprostol kunye novavanyo lwangemva kwonyango. Ileta yasekuqaleni ye-FDA yayisetyenziselwa ukufikelela kwiintsuku ezingama-49 zesigxina, okwenza ukuba kubekho ukhetho lwama-37 ekhulwini lwezigulana zokukhupha isisu. Iifestile yeentsuku ezingama-70 yenza ukuba kubekho ukhetho malunga neepesenti ezingama-75 zezigulise isisu. Izikhokelo ze-2016 zandisa nokuba ngubani onokumisela izilwanyana.
Indlela iMifeprex inikwe ngayo
Imithetho yasekuqaleni ye-RU-486 (iMifeprex) yayidinga ukutyelela kathathu kwiofisi yonyango ngelixa izikhokelo ezihlaziyiweyo zifuna ukuvakatyelelwa omnye ukuya kwembini kuphela. Isilwayo sinokumiselwa kuphela ngugqirha emva kokuvavanya kwe-chorionic gonadotropin (HCG), okulinganisa izinga le-hormone eveliswa emzimbeni ngexesha lokukhulelwa.
Oogqirha banesidingo sokwenza i-sonogram ukuqinisekisa nokuhlawula ukukhulelwa. Izikhokelo ze-2016 zivumela ukuba amayeza asetyenziswe iintsuku ezingama-70 zesigxina (iiveki ezili-10).
Xa ukukhulelwa kuqinisekiswa, uya kunikwa iindidi ezimbini zeyeza. Okokuqala, uya kunikwa umthamo owodwa we-mifepristone, oya kwenza ukuba kube nzima ukuba iqanda elichumayo lihlale linamathele kwimbumba yesisu sakho.
Ekuqaleni, idosi yayiphilisi emithathu, kodwa le nto yancitshiswa ibe yipilisi enye, ithathwe ngomlomo.
Iyeza lesibini, i-misoprostol, ibangela iziphene ze-uterine kwaye ithathwa iintsuku ezimbini emva koko. Isikhokelo esitsha sivumela ukuba silawulwe ekhaya njengamacwecwe amane obeka kwisitram sakho kunokugwinya, ukuvumela ukuba bachithe imizuzu engama-30. Izikhokelo zokuqala, ezigqityiweyo ngamanye amazwe, zifuna ukuba u tyelele ugqirha wakho ukuba athathe le nyibilikiza.
I-Misoprostol iphelisa ukukhulelwa naphi na kwiiyure ezintandathu ukuya kweveki kamva. Kufuneka ulungele ukutyunjwa kunye nokuphuma kwamanzi, okungaqhubeka iintsuku eziliqela.
Umniki-nkonzo wakho wempilo kufuneka ahlole imeko yakho yesixhenxe ukuya kwiintsuku eziyi-14 emva kokuthatha i-mifepristone. I-FDA ayisacacisi ukuba oku kufuneka ukuba ngumntu ohamba naye. Ukuba ukukhulelwa kusekhona, ukukhupha isisu kufuneka kwenziwe.
Iziphumo ezichaphazelekayo ze-RU-486 ziquka i-crater, ukhathala, isicupunu, kunye nokuphuma kwegazi. Uninzi lwabasetyhini luyifumana ngokupheleleyo kwiiyure ezimbalwa ukuya kwiveki. Umyinge wokuphumelela ukukhupha isisu ku-92% ukuya kwi-92.5 ekhulwini kwiiveki zokuqala eziyisixhenxe zokukhulelwa. Oku kushiya ipesenteji encinci yabasetyhini abangadinga utyando olongezelelweyo.
Ukuba ukrokrela ukuba unokukhulelwa kwaye ufuna ukusebenzisa ipilisi yokukhipha isisu ukuphelisa ukukhulelwa kwakho, kufuneka uqhagamshelane nodokotela wakho okanye iklinikhi yendawo ngokukhawuleza ukuba uxoxe ngeendlela ozikhethayo.
Inzuzo kunye neNzuzo
Ezi zinto zimbini ezibalulekileyo zokupheliswa kokuxilongwa kwe-pregnancy yizinga eliphezulu eliphezulu lokuphumelela kunye neyona nto ingenakuchukumisa kwaye ibuhlungu ngaphezu kokukhupha isisu.
Ngokubhekiselele kwimingcipheko, i-Mifeprex ayinakukhetha ukuba ngabafazi abaneengxaki zesibindi okanye iingxaki zeengso, i-anemia, isifo sikashukela, okanye abo bakhuluphele. Akunakusebenza xa kudibene nezinye iziyobisi. Imiphumo emibi ingabandakanyeka ukuncinciza okuncinci, isinambuzane, ukuhlanza, isifo sohudo kunye nokuphuma kwamanzi okuba iintsuku ezisibhozo ukuya kwezi-10.
Utshintsho kwizikhokelo ze-FDA lubonakalisa umendo ngabagqirha abaninzi. Nangona kunjalo, amanye amazwe aye adlulise umthetho ofuna ukunamathela ngokuthe ngqo kwi-labeling ye-FDA kunokuba usetyenziswe ukusetyenziswa kwileyibhile.
Utshintsho lokubhaliweyo lunokwandisa ukufikelela kwesisu sokukhupha isisu.
> Imithombo:
> Ukuphela kokukhulelwa kunye neMithi. MedlinePlus. https://medlineplus.gov/ency/patientinstructions/000835.htm
> Jones RK, i-Boonstra HD. Impembelelo yezeMpilo kaRhulumente ye-FDA Update to Label Label Institute Guttmacher. https://www.guttmacher.org/article/2016/06/public-health-implications-fda-update-medication-abortion-label.
> Mifeprex (mifepristone) Ulwazi. US Food & Drug Administration. https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111323.htm.